| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 3.589 | 5.580 | 603 |
| Total Income - EUR | - | - | - | - | 0 | 15.760 | 9.102 | 12.081 | 5.580 | 3.317 |
| Total Expenses - EUR | - | - | - | - | 3.148 | 29.032 | 27.368 | 35.717 | 28.092 | 23.089 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.148 | -13.272 | -18.266 | -23.636 | -22.513 | -19.772 |
| Net Profit/Loss - EUR | - | - | - | - | -3.148 | -13.272 | -18.266 | -23.672 | -22.562 | -19.872 |
| Employees | - | - | - | - | 3 | 4 | 3 | 4 | 2 | 1 |
Check the financial reports for the company - Daphne Therapy Systems S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.106 | 36.241 | 25.456 | 15.523 | 5.646 | 0 |
| Current Assets | - | - | - | - | 0 | 36.370 | 209 | 15 | -64 | -265 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 36.284 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 0 | 86 | 209 | 15 | -64 | -265 |
| Shareholders Funds | - | - | - | - | -3.148 | -16.360 | -34.263 | -58.041 | -80.428 | -99.850 |
| Social Capital | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | 4.254 | 57.948 | 38.060 | 60.134 | 72.605 | 86.256 |
| Income in Advance | - | - | - | - | 0 | 31.023 | 21.869 | 13.445 | 13.405 | 13.330 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Daphne Therapy Systems S.r.l.